Navigation Links
EBY100 S. cerevisiae Strain from Invitrogen

ProductsEBY100 S. cerevisiae Strain from Invitrogen
Company Invitrogen
Item EBY100 S. cerevisiae Strain
Price 
Description The pYD1 Yeast Display Vector is specifically designed to target and display recombinant proteins on the surface of Saccharomyces cerevisiae. Displayed proteins can be analyzed for their ability to interact with known or putative ligands. pYD1 uses the a-agglutinin yeast adhesion receptor which consists of two domains Aga1 and Aga2 to display recombinant protein on the surface of S. cerevisiae. The gene of interest is cloned into the pYD1 vector in frame with the AGA2 gene. The resulting construct is transformed into the EBY100 S. cerevisiae strain (supplied transformed with Aga1). Aga1 and the Aga2-fusion protein associate within the secretory pathway and are displayed on the cell surface (Figure 1).
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site: http://www.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Bakers yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
2. Bakers yeast (S. cerevisiae) S-Acetyl-coenzyme A synthetase from Sigma-Aldrich
3. Enolase from bakers yeast (S. cerevisiae) from Sigma-Aldrich
4. Bakers yeast (S. cerevisiae) Hexokinase and glucose-6-phosphate dehydrogenase from Sigma-Aldrich
5. S. cerevisiae Direct Transformation Kit from Wako Chemicals USA, Inc.
6. S. cerevisiae Direct Transformation Kit from Wako Chemicals USA, Inc.
7. S. cerevisiae yeast Whole Genome from Agilent Technologies
8. S. cerevisiae yeast Whole Genome from Agilent Technologies
9. Ribonucleic acid, transfer from bakers yeast (S. cerevisiae) from Sigma-Aldrich
10. Ribonucleic acid, transfer from bakers yeast (S. cerevisiae) from Sigma-Aldrich
11. Ribonucleic acid, transfer from bakers yeast (S. cerevisiae) from Sigma-Aldrich
Formula variant: With macro- and micronutrients. Physical Form: powder Suitab tst: plant cell culture tested...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
... Drosophila S2 cells are used for ... Expression System (DES). The S2 cell line ... stage (20-24 hours old) Drosophila melanogaster ... rapidly at room temperature without CO2 and is ...
Biology Products:
(Date:6/11/2019)... ... June 12, 2019 , ... With ... Abveris plans to leverage the Geneious Biologics platform as a premium hub for ... Officer at Abveris, says: “The Geneious team has done an excellent job accommodating ...
(Date:6/6/2019)... ... 05, 2019 , ... MedTech Breakthrough , an independent ... medical technology market, announced that it has selected Medacta International’s MySpine® MC platform ... the 2019 MedTech Breakthrough Awards program. , Medacta® is an ...
(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, a specialty investment bank, ... Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. , Headquartered in ... to more than one dozen hospitals and surgery centers in the Dallas-Fort Worth ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the ... National Corn Growers Association (NCGA) announced the winners of the Consider Corn ... product or process using field corn to produce biobased materials. , “Corn is a ...
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, Inc ... application to the FDA for use of a person’s own adipose-derived stem cells to ... osteoarthritis in the knee. This IND is the first of several planned clinical ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, ... a national leader in opioid treatment, announced today they are partnering to combat ... Mytonomy recently deployed its virtual care platform at the Mayo Clinic to drive ...
(Date:5/31/2019)... California (PRWEB) , ... May ... ... of our patent applications from the USPTO providing proprietary interest to our ... METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including ...
Breaking Biology Technology: